-
Sale!
$1,394.99 Original price was: $1,394.99.$697.49Current price is: $697.49.
Mounjaro® (Tirzepatide) Injection 10 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only)
Refrigeration Required
At Weight Loss RX, we offer prescription-based therapies designed to support blood sugar control and physician-guided weight management.
Mounjaro® (tirzepatide) is a once-weekly injectable prescription medication approved for adults with type 2 diabetes. It is part of a newer class of medications that target two hormone receptors involved in blood sugar regulation and appetite control. Tirzepatide works as both a GLP-1 (glucagon-like peptide-1) receptor agonist and a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, allowing for more comprehensive metabolic support than traditional GLP-1 therapies alone.
-
Sale!
$1,394.99 Original price was: $1,394.99.$697.49Current price is: $697.49.
Mounjaro® (Tirzepatide) Injection 12.5 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only)
Refrigeration Required
At Weight Loss RX, we provide access to advanced prescription therapies that support blood sugar control and medically supervised weight management.
Mounjaro® (tirzepatide) is a once-weekly injectable prescription medication approved for adults with type 2 diabetes. It is a unique medication that works on two key hormone pathways, making it different from traditional GLP-1 therapies. Tirzepatide acts as both a GLP-1 receptor agonist and a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, helping the body regulate blood sugar more effectively.
-
Sale!
$1,394.99 Original price was: $1,394.99.$697.49Current price is: $697.49.
Mounjaro® (Tirzepatide) Injection 7.5 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only)
Refrigeration Required
At Weight Loss RX, we provide prescription-only injectable therapies designed to support blood sugar control and medically supervised weight management.
Mounjaro® (tirzepatide) is a once-weekly injectable prescription medication approved for adults with type 2 diabetes. It belongs to an advanced class of medications that target two key hormone pathways involved in glucose regulation and appetite control. Tirzepatide acts as both a GLP-1 (glucagon-like peptide-1) receptor agonist and a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, offering broader metabolic support than traditional GLP-1 therapies alone.
